Press

Launch of the lighting program

Protective eyewear against laser light

Illumination of the surgical cavity

Injection of the diffuser liquid into the applicator

Illumination of the surgical cavity

Inserting the optical fiber into the Heliance® applicator

Illumination of the surgical cavity

Heliance illumination platform diffuser

Heliance platform trolley

Setting the illumination sequence

Setting the illumination sequence

Heliance illumination platform diffuser

Heliance illumination platform diffuser

Heliance Illumination Platform

Heliance Illumination Platform

Heliance Illumination Platform

Press kit – October 2025

Maximilien Vermandel, Chief Executive Officer (CEO)

Clément Dupont, Chief Technical Officer (CTO)

Michel Andraud, Chief Financial Officer (CFO)

Mélanie Rose, Research scientist

Dr Nicolas Reyns, founder and member of the Scientific Advisory Board

Professor Serge Mordon, member of the Scientific Advisory Board

Luciola Jáuregui Teniente, Manager, Regulatory Affairs

Antoine Méquignon, Manager of the Clinical Affairs Department

Use of Heliance® in the operating theatre

Preparation of the optical fibre

Shooting in the operating theatre

Mélanie Rose at Lesaffre

Training a neurosurgery team in Pentalafen® / Heliance® combination therapy at the University Medical Center of Pittsburgh

Use of Heliance® technology in the operating theatre during a glioblastoma operation

Hemerion head office in Villeneuve d’Ascq (France)

Operation on the first patient included in the HTX-GBM-01 trial for the treatment of glioblastoma in Pittsburgh

Details of the lighting system

Application of the applicator in the treatment of glioblastoma in the operating theatre

The elements of Pentalafen® / Heliance® combined therapy

Shooting in the operating theatre

Setting an illumination sequence for Pentalafen® / Heliance® combination therapy